KOPS - Das Institutionelle Repositorium der Universität Konstanz

In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice

In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice

Zitieren

Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

MANEA, Marilena, József TÓVÁRI, Miguel TEJEDA, Ákos SCHULCZ, Bence KAPUVÁRI, Borbála VINCZE, Gábor MEZŐ, 2012. In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice. In: Anti-Cancer Drugs. 23(1), pp. 90-97. ISSN 0959-4973. eISSN 1473-5741. Available under: doi: 10.1097/CAD.0b013e32834bb6b4

@article{Manea2012-01Inviv-17234, title={In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice}, year={2012}, doi={10.1097/CAD.0b013e32834bb6b4}, number={1}, volume={23}, issn={0959-4973}, journal={Anti-Cancer Drugs}, pages={90--97}, author={Manea, Marilena and Tóvári, József and Tejeda, Miguel and Schulcz, Ákos and Kapuvári, Bence and Vincze, Borbála and Mező, Gábor} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/17234"> <dcterms:abstract xml:lang="eng">Targeted cancer chemotherapy is a novel approach developed for the specific delivery of anticancer drugs. Tumour targeting can be achieved by combining a chemotherapeutic agent with a targeting moiety that recognizes tumour-specific or highly expressed receptors on cancer cells. We used the gonadotropin-releasing hormone-III (GnRH-III) as a targeting moiety to which the chemotherapeutic agent daunorubicin (Dau) was attached through an oxime bond either directly or by inserting a GFLG tetrapeptide spacer. The in-vivo toxicity of Dau-GnRH-III derivative conjugates was evaluated on healthy BDF-1 female mice, and their tumour growth inhibitory effect was determined on C26 murine and HT-29 human colon carcinoma-bearing mice. Both oxime bond-containing conjugates were well tolerated and exerted significant antitumour activity on C26 colon carcinoma-bearing mice at a dose of 30 mg Dau content in conjugate/kg body weight. Furthermore, the conjugates inhibited the tumour growth more than the free drug at a dose that was still not toxic. Similar tumour growth inhibitory effects were obtained on HT-29 human colon carcinoma-bearing mice using three treatments with 15 mg Dau content in conjugate/kg. The tumour growth inhibitions according to the tumour volume and the tumour weight were 44/41% and 58/50%, respectively. Considering the results, both of the investigated Dau-GnRH-III derivative conjugates were well tolerated and had significant antitumour effect on colon carcinoma-bearing mice.</dcterms:abstract> <dcterms:bibliographicCitation>Publ. in: Anti-Cancer Drugs ; 23 (2012), 1. - S. 90–97</dcterms:bibliographicCitation> <dc:language>eng</dc:language> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dcterms:title>In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice</dcterms:title> <dc:contributor>Vincze, Borbála</dc:contributor> <dc:creator>Mező, Gábor</dc:creator> <dc:creator>Tejeda, Miguel</dc:creator> <dc:creator>Kapuvári, Bence</dc:creator> <dc:contributor>Manea, Marilena</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/29"/> <dc:creator>Schulcz, Ákos</dc:creator> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/17234"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/52"/> <dc:contributor>Schulcz, Ákos</dc:contributor> <dc:contributor>Mező, Gábor</dc:contributor> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103605204-4002607-1"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-11-30T14:36:33Z</dc:date> <dc:creator>Tóvári, József</dc:creator> <dc:contributor>Tóvári, József</dc:contributor> <dc:rights>deposit-license</dc:rights> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/52"/> <dc:creator>Vincze, Borbála</dc:creator> <dc:contributor>Kapuvári, Bence</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-11-30T14:36:33Z</dcterms:available> <dc:contributor>Tejeda, Miguel</dc:contributor> <dcterms:issued>2012-01</dcterms:issued> <dc:creator>Manea, Marilena</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/29"/> </rdf:Description> </rdf:RDF>

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto